Rachel Cohrs

The renewal eliminates the risk of a lapse as the Biden administration takes over.

Democrats will have much more latitude to pursue their healthcare agenda with a trifecta government.

Specialty physician groups successfully fought to mitigate pay cuts after the Medicare Physician Fee Schedule was released.

HHS' advisory opinion doesn't have the force of law and some drugmakers have signaled defiance.

HHS issued an advisory opinion in support of covered entities.

The years-long battle involved mudslinging and big spending by some of Washington's most powerful healthcare industry interests. The chaotic final sprint ended with major capitulations to healthcare providers.

Providers have demonstrated an ability to comply with a limited ban on balance billing COVID-19 patients as a condition of keeping roughly $125 billion in grant funds.

A federal judge in Maryland delayed CMS' implementation of its most-favored nation Medicare reimbursement demonstration by 14 days.

Congress authorized Medicare to support 1,000 new GME slots in its year-end legislative package.

The bill allows the Justice Department and the Federal Trade Commission to regulate health insurance markets.

Lawmakers on Monday released details of major COVID-19 relief and government funding legislation, including many provisions important to the healthcare industry.

The most-favored nation demonstration that would cut provider reimbursement for Medicare Part B drugs is supposed to go into effect on Jan. 1, 2021.

Eight lawmakers that lead key committees didn't ask to curb gag clauses or various types of clauses that would make it difficult for plans to steer consumers to lower-cost or higher-quality providers.

Some insurers are concerned that the Biden administration could overturn Trump-era guidance that limited their testing liability.

Modern Healthcare on Dec. 9 held a virtual town hall with four healthcare policy leaders to get their perspectives on the most pressing issues facing the new administration.